Figure
Henrietta Lacks was a Black tobacco farmer, wife, and mother of five who was treated for cervical cancer at Johns Hopkins Hospital in 1951. Cells taken from her tumour without her knowledge became HeLa, the first widely shared human cell line able to grow continuously in laboratories.
Lacks matters as a person and patient, not merely as the source of useful cells. Her history connects biomedical discovery to segregated care, absent consent, commercial value, family privacy, and the question of what researchers owe the people whose tissues make science possible.
Patient and Cell Line
Lacks sought care for abnormal bleeding at a hospital that treated Black patients in segregated wards. During diagnosis and treatment, tumour tissue was passed to George Gey's laboratory without asking her permission, consistent with practices then permitted but ethically unacceptable by current expectations.
Earlier human cultures usually died after limited divisions. Cells from Lacks's aggressive cancer reproduced rapidly under laboratory conditions, allowing researchers to repeat experiments and distribute a common biological material.
HeLa cells supported work in virology, cancer biology, radiation, toxicology, genetics, vaccines, and space research. Their usefulness depended on cell-culture workers, laboratories, repositories, standardisation, and global exchange.
The cells flourished while Lacks's cancer progressed. She died in October 1951 at thirty-one. Narratives celebrating immortality can obscure the pain of her illness and the unequal medical world in which she received care.
Researchers later contacted relatives for blood samples and genetic studies without initially providing clear explanations. Public identification of Lacks and publication of genetic information created privacy questions affecting descendants as well as the original patient.
Life before HeLa
Born Loretta Pleasant in Virginia, she grew up in a family shaped by tobacco farming and the legacies of slavery. She married David Lacks and later moved to Turner Station, a Black community near Baltimore built around industrial work.
Her life included children, kinship, labour, dancing, illness, and care. Restoring these dimensions resists a laboratory shorthand that compressed a woman into the first two letters of her names.
The history also includes technician Mary Kubicek, who cultured samples, and the Gey laboratory that distributed cells. Recognising laboratory labour need not transfer ownership of the story away from Lacks.
Ethics and Governance
HeLa became commercially valuable while the Lacks family received no share of that early economy and sometimes lacked access to health care. The case does not map neatly onto every tissue study, but it made structural inequality impossible to ignore.
In 2013 the National Institutes of Health reached an agreement with family representatives governing access to controlled HeLa genomic data and including family members in review. The arrangement was not retroactive consent; it was a negotiated response to continuing privacy and governance concerns.
Modern ethics asks whether legal permission is enough, how clearly future uses should be explained, who benefits, and how communities participate in decisions. Lacks's history keeps those questions attached to a human life.
Across the collection
Trace consent, tissue ownership, privacy, exploitation, and benefit.
Follow cell culture, standardisation, technical labour, and circulation.
Connect patient experience to pathology, radiation, and research.